China biotech startup InventisBio bags a $19M round for early-stage R&D
The flow of venture cash in and out of China’s biotech scene includes a new $19 million round today for Shanghai-based InventisBio, which has been …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.